Costa Rica vs Montenegro: Access to anti-retroviral drugs, male
Costa Rica
61.0%
in 2024
Montenegro
61.0%
in 2024
Costa Rica rank
97th
Montenegro rank
97th
Access to anti-retroviral drugs, male over time
- Costa Rica
- Montenegro
How they compare
Costa Rica currently reports 61.0% against 61.0% in Montenegro, a difference of 0.0%.
The two have swapped places 7 times across 25 shared years of data; in 2000 it was Costa Rica ahead.
Costa Rica ranks 97th and Montenegro ranks 97th of 141 countries.
Costa Rica has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Costa Rica | Montenegro | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 16.2% | 14.5% | 1.7% | Costa Rica |
| 2010s | 40.8% | 36.8% | 4.0% | Costa Rica |
| 2020s | 59.2% | 56.4% | 2.8% | Costa Rica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Costa Rica or Montenegro?
- Costa Rica, at 61.0% against 61.0% in Montenegro as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Costa Rica and Montenegro?
- 0.0%, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and Montenegro?
- 25 years are reported by both, from 2000 to 2024.
- How do Costa Rica and Montenegro rank globally for access to anti-retroviral drugs, male?
- Costa Rica ranks 97th and Montenegro ranks 97th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.